Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|9|1|30-40

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.9, Iss.1, 2012-01, pp. : 30-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 689-700

Bentham Science Publishers

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Novel and Emerging Drugs for Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 471-483

Bentham Science Publishers

Access to resources Recommend Favorite

New treatment options for chronic lymphocytic leukemia

By Delgado Julio Baumann Tycho Santacruz Rodrigo Montserrat Emili

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite